ArticleMolecular cancer therapeutics2024

Integrated Imaging Probe and Bispecific Antibody Development Enables In Vivo Targeting of Glypican-3-Expressing Hepatocellular Carcinoma.

Peiman Habibollahi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.